TY  - JOUR
AU  - Tabar, Ana Isabel
AU  - Prieto, Luis
AU  - Alba, Pilar
AU  - Nieto, Antonio
AU  - Rodríguez, Mercedes
AU  - Torrecillas, Miguel
AU  - Huertas, Beatriz
AU  - Gómez, Elisa
AU  - Fernández, Francisco Javier
AU  - Blanca, Miguel
AU  - Rodríguez, David
AU  - Palacios, Ricardo
PY  - 2019
DO  - 10.1016/j.jaci.2019.02.029
UR  - http://hdl.handle.net/10668/13722
T2  - The Journal of allergy and clinical immunology
AB  - There have been few studies conducted on the efficacy and safety of specific immunotherapy with allergen extracts of fungi compared with other allergen extracts, and there are no data on the major allergen Alt a 1 of the fungus Alternaria alternata....
LA  - en
KW  - Allergen immunotherapy
KW  - Alt a 1
KW  - adults
KW  - children
KW  - clinical trial
KW  - efficacy
KW  - fungal allergy
KW  - molecular immunotherapy
KW  - purified allergen
KW  - rhinoconjunctivitis
KW  - safety
KW  - subcutaneous immunotherapy
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Allergens
KW  - Asthma
KW  - Child
KW  - Conjunctivitis, Allergic
KW  - Desensitization, Immunologic
KW  - Double-Blind Method
KW  - Female
KW  - Fungal Proteins
KW  - Humans
KW  - Immunoglobulin E
KW  - Immunoglobulin G
KW  - Male
KW  - Middle Aged
KW  - Young Adult
TI  - Double-blind, randomized, placebo-controlled trial of allergen-specific immunotherapy with the major allergen Alt a 1.
TY  - research article
VL  - 144
ER  -